GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients
| Description | |
| Date de publication | |
| Auteurs | Cox DG, Curtit E, Romieu G, Fumoleau P, Rios M, Bonnefoi H, Bachelot T, Soulie P, Jouannaud C, Bourgeois H, Petit T, Tennevet I, Assouline D, Mathieu MC, Jacquin JP, Lavau-Denes S, Darut-Jouve A, Ferrero JM, Tarpin C, Levy C, Delecroix V, Trillet-Lenoir V, Cojocarasu O, Meunier J, Pierga JY, Faure-Mercier C, Blanche H, Sahbatou M, Boland A, Bacq D, Besse C, Deleuze JF, Pauporte I, Thomas G and Pivot X |
| Revue | |
| Année | 2,016 |
| Département / Service | |
| Laboratoire | |
| Impact Factor | 5.17 |
| Institut | IG |
| url DOI | 10.18632/oncotarget.12669 |